Literature DB >> 17996976

Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis.

Y-N Li1, H-Z Shi, Q-L Liang, H-B Yang, G-M Huang.   

Abstract

OBJECTIVE: Cytologic approaches such as pleural lavage cytology (PLC) are considered as possible aids to assessing prognosis of lung cancer patients. We aimed to comprehensively review the evidence for use of PLC to predict prognosis of lung cancer.
METHODS: Fifteen studies, including 6391 patients, were found to be eligible for the present meta-analysis. A meta-analysis was done on the log hazard ratios and their variances in these studies.
RESULTS: Four studies dealt with pleural lavage before lung resection, six studies dealt with pleural lavage after lung resection, and five studies had PLC data from both before and after lung resection examination. For before lung resection studies, combined hazard ratios showed that positive PLC results had an unfavorable impact on survival: 3.96 (95% confidence interval 2.48-6.33), 4.55 (2.95-7.04), 5.00 (3.39-7.36), 5.67 (3.81-8.43), and 7.06 (5.04-9.90), for 1-, 2-, 3-, 4- and 5-year, respectively. For after lung resection studies, combined hazard ratios showed that positive PLC results had an unfavorable impact on survival: 6.02 (3.74-9.71), 6.64 (4.53-9.72), 7.06 (4.93-10.12), 7.29 (5.18-10.25), and 8.47 (6.12-11.73), for 1-, 2-, 3-, 4- and 5-year, respectively. Totally, the combined hazard ratio was 5.61 (3.98-7.90), showing a worse survival when PLC was positive. These findings could be overestimated because of publication and reporting bias.
CONCLUSIONS: PLC is a strong prognostic factor for survival in patients with lung cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17996976     DOI: 10.1016/j.lungcan.2007.09.024

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  The influence of intraoperative pleural perfusion with matrine-cisplatin or cisplatin on stromal cell-derived factor-1 in non-small cell lung cancer patients with subclinical pleural metastasis.

Authors:  Cheng-Liang Yang; Shun-Shou Liu; Ye-Gang Ma; Yong-Yu Liu; Yi-Xue Xue; Bo Huang
Journal:  Med Oncol       Date:  2011-02-11       Impact factor: 3.064

Review 2.  The role of surgical intervention in lung cancer with carcinomatous pleuritis.

Authors:  Takayuki Fukui; Kohei Yokoi
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Diagnostic value of medical thoracoscopy in malignant pleural effusion.

Authors:  Yan-Bing Wu; Li-Li Xu; Xiao-Juan Wang; Zhen Wang; Jun Zhang; Zhao-Hui Tong; Huan-Zhong Shi
Journal:  BMC Pulm Med       Date:  2017-08-04       Impact factor: 3.317

4.  Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.

Authors:  Chun-Mei Wang; Zhou-Gui Ling; Yan-Bin Wu; Shuang-Qi Cai; Zhen-Ming Tang; Cong Wu; Yi-Qiang Chen
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

Review 5.  [Latest Progress of Intraoperative Pleural Lavage Cytology in Lung Cancer Surgery].

Authors:  Donglai Chen; Ranran Fu; Pingfan Shi; Shuang Qin; Chang Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.